Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. Signal., 18 August 2009
[DOI: 10.1126/scisignal.2000053]

Supplementary Materials for:

Differential p53-Independent Outcomes of p19Arf Loss in Oncogenesis

Zhenbang Chen, Arkaitz Carracedo, Hui-Kuan Lin, Jason A. Koutcher, Nille Behrendt, Ainara Egia, Andrea Alimonti, Brett S. Carver, William Gerald, Julie Teruya-Feldstein, Massimo Loda, Pier Paolo Pandolfi*

*To whom correspondence should be addressed. E-mail: ppandolf{at}

This PDF file includes:

  • Fig. S1. Generation of p19Arf–/–;Ptenpc–/– mice and visualization of prostate tumors.
  • Fig. S2. Immunohistochemical analysis of p21 in mouse prostate.
  • Fig. S3. In vitro characterization of p19Arf–/–-PtenΔ/Δ double-null MEFs.
  • Fig. S4. Lack of correlation between p53 and p14ARF expression in human prostate cancer biopsies.
  • Fig. S5. Nucleophosmin abundance and localization in MEFs.

[Download PDF]

Technical Details

Format: Adobe Acrobat PDF

Size: 3.7 MB

Citation: Z. Chen, A. Carracedo, H.-K. Lin, J. A. Koutcher, N. Behrendt, A. Egia, A. Alimonti, B. S. Carver, W. Gerald, J. Teruya-Feldstein, M. Loda, P. P. Pandolfi, Differential p53-independent outcomes of p19Arf loss in oncogenesis. Sci. Signal. 2, ra44 (2009).

© 2009 American Association for the Advancement of Science

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882